Publication | Closed Access

Long-Term Results of Monoclonal Anti-Il2-Receptor Antibody Versus Polyclonal Antilymphocyte Antibodies as Induction Therapy in Renal Transplantation

Transplant RejectionUrologyTransplantationAutoimmune DiseaseKidney TransplantKidney TransplantationImmunosuppressive TherapyImmunologyAutoimmunityGraft RejectionRenal TransplantationImmunotherapyMedicineNephrologyInduction TherapyLong-term Results